Patient compliance and disease management in the treatment of psoriasis in the Netherlands

Dermatology

Volumn 200, Issue 4, 2000, Pages 292-298

  Van De Kerkhof, P C M ^a   De Hoop, D ^b   De Korte, J ^c   Cobelens, S A ^d   Kuipers, M V ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GELDERSE VALLEI HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Departments of Dermatology   (Netherlands)

Author keywords

Acitretin; Calcipotriol; Compliance; Methotrexate; Psoriasis

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; ETRETIN; FUMARIC ACID; METHOTREXATE; SALICYLIC ACID; TAR;

ADOLESCENT; ADULT; AGED; CHILD; CONFERENCE PAPER; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PATIENT COMPLIANCE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; SAFETY; ULTRAVIOLET B RADIATION;

EID: 0033918656     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018390     Document Type: Conference Paper

References (15)

1. Poyner TF, Fell PJ: A summary of patients with plaque psoriasis who had not consulted their doctor in the past year. Br J Clin Res 1955;6:201-207.
2. Van de Kerkhof PCM, de Hoop D, de Korte J, Kuipers MV: Scalp psoriasis, clinical presentations and therapeutic management. Dermatology 1998;197:326-334.
3. Van de Kerkhof PCM, Steegers-Theunissen RPM, Kuipers MV: Evaluation of topical drug treatment in psoriasis. Dermatology 1998;197: 31-36.
4. Farber EM, Nall ML: The natural history of psoriasis in 5,600 patients. Dermatologica 1974;148:1-18.
5. Finlay AY, Coles EC: The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-244.
6. Kragballe K, Fogh K; Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Acta Derm Venereol (Stockh) 1991;71:475-478.
7. Ramsay B, O'Reagan M: A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988;118:195-201.
8. Cullen SI: Long-term effectiveness and safety of topical calcipotriene for psoriasis. South Med J 1996;89:1053-1056.
9. Marks R, Barton S, Shuttleworth D, Finlay AY: Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:235-240.
10. Ramsay B, Lawrence CM: Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991;124:565-570.
11. Van de Kerkhof PCM: On the psoriasis area and severity index. Br J Dermatol 1992;126: 205.
12. Camp RDR: Psoriasis; in Champion RH, Burton JL, Burns DA, Breathnack SM (eds): Rook, Wilkinson, Ebling, Textbook of Dermatology, Oxford Blackwell Science, pp 1589-1650.
13. Van de Kerkhof PCM: Combinations and comparisons. Clin Dermatol 1997;15:831-834.
14. Studniberg HM, Weller P: PUVA, UVB, psoriasis and nonmelanoma skin cancer. J Am Acad Dermatol 1993;29:1013-1022.
15. Rosenstock IM: Understanding and enhancing patient compliance with diabetic regimens. Diabetes Care 1985;9:610-618.